$0 0.0 0.0%
Last Trade - 25/02/19
| Market Cap | £n/a |
| Enterprise Value | £n/a |
| Revenue | £26.8k |
| Position in Universe | th / 6850 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Oct | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014E | 2015E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.000 | 0.003 | 0.016 | 0.054 | 0.005 | 0.021 | |||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
BioNeutral Group, Inc. is a life science specialty technology company. The Company has developed a novel combinational chemistry-based technology which can, in certain circumstances, neutralize harmful environmental contaminants, toxins and dangerous micro-organisms, including bacteria, viruses and spores. The Company is focused on developing and commercializing two classes of product formulations: antimicrobials, which are formulations designed to kill certain harmful microscopic living organisms, and bioneutralizers, which are formulations designed to destroy certain agents that are noxious and harmful to health and/or the environment. The Company refers to its antimicrobial formulations as its Ygiene products and its bioneutralizer formulations as its Ogiene products.
| Last Annual | October 31st, 2013 |
| Last Interim | July 31st, 2014 |
| Incorporated | April 10, 2007 |
| No. of Shareholders: | 175 |
| No. of Employees: | 3 |
| Sector | Industrials |
| Industry | Professional & Commercial Services |
| Index | |
| Exchange | Pink Sheets on Nasdaq |
| Shares in Issue | 5,751,790,172 |
| Free Float | (0.0%) |
| Eligible for |
×
ISAs
✓
SIPPs
|
| Address | 211 Warren St, NEWARK, 07103-3568, United States |
| Web | |
| Phone | +1 973 2862899 |
| Contact | () |
| Auditors | Marcum LLP |
As of 25/02/19, shares in Bioneutral Inc are trading at $0, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.
Shares in Bioneutral Inc are currently trading at $0 and the price has moved by -99% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Bioneutral Inc price has moved by -99.33% over the past year.
There are no analysts currently covering Bioneutral Inc.
Bioneutral Inc is scheduled to issue upcoming financial results on the following dates:
Bioneutral Inc does not currently pay a dividend.
Bioneutral Inc does not currently pay a dividend.
Bioneutral Inc does not currently pay a dividend.
To buy shares in Bioneutral Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Bioneutral Inc are currently trading at $0, giving the company a market capitalisation of £n/a.
Here are the trading details for Bioneutral Inc:
We were not able to load our ranking data for Bioneutral Inc
We were not able to load any forecast data for Bioneutral Inc.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bioneutral Inc. Over the past six months, the relative strength of its shares against the market has been -91.84%. At the current price of $0, shares in Bioneutral Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Bioneutral Inc.
We were unable to find the directors for Bioneutral Inc.
Here are the top five shareholders of Bioneutral Inc based on the size of their shareholding:
